Document is current
Any future updates will be listed below
-
Authors
White, Becky https://orcid.org/0000-0002-0643-7890
Rafiq, Meena
Gonzalez-Izquierdo, Arturo
Hamilton, Willie
Price, Sarah https://orcid.org/0000-0002-2228-2374
Lyratzopoulos, Georgios https://orcid.org/0000-0002-2873-7421
-
Funding
Funding for this research was provided by:
Cancer Research UK (C8640/A23385, C18081/A18180, C18081/A31373, C18081/A18180, C8640/A23385 [, C18081/A31373, C8640/A23385, C8640/A23385, C18081/A18180, C18081/A31373)
- License Information
-
More Information
Article History
Received: 29 June 2021
Revised: 12 January 2022
Accepted: 1 February 2022
First Online: 18 February 2022
Ethics approval and consent to participate
: This study was approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) Independent Scientific Advisory Committee (ISAC Protocol number 18_299RMnA5), under Section 251 (NHS Social Care Act 2006). This study is based on data from the CPRD obtained under licence from the MHRA. The data are provided by patients and collected by the NHS as part of their care and support. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
